DAX19.232 +0,5%ESt504.766 +0,2%MSCIW3.754 ±0,0%Dow43.870 +1,1%Nas18.972 ±0,0%Bitcoin94.665 +0,6%Euro1,0419 -0,5%Öl73,71 -0,9%Gold2.699 +1,1%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
NVIDIA 918422 MicroStrategy 722713 Tesla A1CX3T Rheinmetall 703000 Bayer BAY001 Amazon 906866 Siemens Energy ENER6Y Volkswagen (VW) vz. 766403 Coinbase A2QP7J NEL ASA A0B733 Mercedes-Benz Group (ex Daimler) 710000 Deutsche Telekom 555750 Palantir A2QA4J Porsche PAG911 EVOTEC 566480
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
Schwache Unternehmensstimmung: DAX fester -- Bitcoin knapp vor 100.000 US-Dollar -- Chef der US-Börsenaufsicht tritt ab -- RWE, Secunet, NEL im Fokus
Top News
BÖRSE AKTUELL: Erneuter Vorzeichenwechsel an Frankfurter Börse - DAX zurück im Plus BÖRSE AKTUELL: Erneuter Vorzeichenwechsel an Frankfurter Börse - DAX zurück im Plus
Jetzt mit OSKAR black in ETFs investieren - Für Anlagesummen ab 50.000 Euro (Werbung) Jetzt mit OSKAR black in ETFs investieren - Für Anlagesummen ab 50.000 Euro (Werbung)
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil
Wer­bung
Exklusiver Live-Stream direkt von der World of Trading - 2 Tage mit einzigartigen Themen und Experten. Kostenlos teilnehmen + Videos erhalten.

Poxel SA Aktie

NeuKaufenVerkaufen
0,2105 EUR -0,0035 EUR -1,64 %
STU
0,2285 EUR -0,0050 EUR -2,14 %
PAR
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!
JETZT LOSLEGEN
Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handelnSmartphone

Marktkap.12,52 Mio. EUR

Div. Rendite0,00%

WKNA14M04

ISINFR0012432516

SymbolPXXLF

Poxel SA Aktien News

DatumMeistgelesen
BusinesswirePoxel Reports Cash and Revenue for the Third Quarter and Nine Months 2024 and Provides Corporate Update
BusinesswirePoxel Announces Agreement with OrbiMed to Monetize a portion of TWYMEEG® Royalties for USD 50 million
BusinesswirePoxel Reports Revenue for the Second Quarter and First Half 2024 and Provides Corporate Update
Wer­bungPoxel SA-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero
BusinesswireSumitomo Pharma and Poxel Announce Topline Results from Post-Marketing Clinical Study on TWYMEEG® for the Treatment of Type 2 Diabetes in Japan
BusinesswirePoxel Provides an Update on Its Financial Position for the Second Quarter and First Half of 2024 and Announces the Rescheduling of Its Annual General Meeting
BusinesswirePoxel Reports Revenue for the First Quarter 2024 and Provides Corporate Update
BusinesswirePoxel Provides a Financial Update for the First Quarter 2024 and Announces the Postponement of its 2023 Full-Year Results Release
BusinesswirePoxel to Report Its 2023 Annual Results by the End of April 2024
BusinesswirePoxel Reports Cash and Revenue for the Full Year 2023 and Provides Corporate Update
BusinesswirePoxel Announces its Financial Calendar for 2024
BusinesswirePoxel Provides Corporate Update
BusinesswirePoxel Provides Corporate Update and Reports Cash and Revenue for the Third Quarter and Nine Months 2023
BusinesswirePoxel Announces its Participation at Upcoming Investor Conferences
BusinesswirePoxel Announces its Participation at Upcoming Scientific Conference
BusinesswirePoxel Reports Financial Results for First Half 2023 and Provides a Corporate Update
BusinesswirePoxel to Report 2023 First Half-Year Results and host a video conference on September 26, 2023
BusinesswirePoxel Reports Cash and Revenue for the Second Quarter and First Half 2023 and Provides Corporate Update
BusinesswirePoxel Announces Upcoming Participation at the H.C. Wainwright 2nd Annual Kidney Conference
BusinesswirePoxel, winner of the 2023 edition of the I-nov contest
BusinesswirePoxel Announces the Approval of a Prospectus for the Listing of New Shares on Euronext Paris
BusinesswirePoxel Announces Results from June 21, 2023 Ordinary Annual and Extraordinary General Meeting
BusinesswirePoxel Announces its Participation at Patient Association Conferences in Adrenoleukodystrophy
BusinesswirePoxel Reports Cash and Revenue for the First Quarter 2023 and Provides Corporate Update
BusinesswirePoxel Announces Notice of Its Annual General Meeting to Be Held on June 21, 2023
BusinesswirePoxel Announces TWYMEEG® (Imeglimin) Fiscal Year 2022 Sales
BusinesswirePoxel Announces Upcoming Participation at the JMP Securities Life Science Conference
BusinesswirePoxel Announces Multiple TWYMEEG® (Imeglimin) Abstracts Accepted for Oral Presentation
BusinesswirePoxel Announces Cash Runway Extended Through Q2 2025 Based upon Debt Restructuring Agreement and New Equity-linked Financing Facility
BusinesswirePoxel Reports Financial Results for Full Year 2022 and Provides Corporate Update
BusinesswirePoxel Announces Upcoming Participation at Evercore ISI’s NASH Renaissance Event
BusinesswirePoxel Announces Publication of Positive Phase 2 Results from Phase 2 NASH Trial (DESTINY-1) for PXL065 in Journal of Hepatology
BusinesswirePoxel Announces Publication in Kidney International of PXL770 Preclinical Results in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
BusinesswirePoxel Reports Cash and Revenue for the Full Year 2022 and Provides Corporate Update
BusinesswirePoxel Receives Orphan Drug Designation from the European Commission for PXL770 and PXL065 for Treatment of Adrenoleukodystrophy
BusinesswirePoxel Announces its Financial Calendar for 2023
BusinesswirePoxel Announces Drawdown of the Remaining Two Tranches of its Equity-linked Financing Facility and Provides Corporate Update
BusinesswirePoxel Provides Corporate Update and Reports Cash and Revenue for the Third Quarter and Nine Months 2022
BusinesswirePoxel Presents DESTINY-1 Phase 2 Results for PXL065 in NASH at AASLD The Liver Meeting® 2022
BusinesswirePoxel Announces Upcoming Participation at the Jefferies London Healthcare Conference
BusinesswirePoxel Announces Upcoming Presentation at the H.C. Wainwright 6th Annual NASH Investor Virtual Conference

Poxel SA News

Poxel SA News: auf dieser Seite finden Sie alle Poxel SA News und Nachrichten zur Poxel SA Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Poxel SA News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Poxel SA News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.